Since most studies are conducted internationally, the investigational drugs must be reliably marked and provided with a complete set of important information in several languages. Sanofi needed a multi-page label for a needle protection system to be used in a phase III clinical trial—and Schreiner MediPharm’s CTS team found the solution precisely meeting these needs.
